P, P., J, L., F, B., L, J., M, S., A, G., . . . S, F. (2026). Zip-Code Level Disadvantage as a Predictor of Metastatic Breast Cancer at Diagnosis and Delayed Treatment Initiation. Annals of surgical oncology, 33(3), 2306. https://doi.org/10.1245/s10434-025-18693-9
Chicago Style (17th ed.) CitationP, Parmar, et al. "Zip-Code Level Disadvantage as a Predictor of Metastatic Breast Cancer at Diagnosis and Delayed Treatment Initiation." Annals of Surgical Oncology 33, no. 3 (2026): 2306. https://doi.org/10.1245/s10434-025-18693-9.
MLA (9th ed.) CitationP, Parmar, et al. "Zip-Code Level Disadvantage as a Predictor of Metastatic Breast Cancer at Diagnosis and Delayed Treatment Initiation." Annals of Surgical Oncology, vol. 33, no. 3, 2026, p. 2306, https://doi.org/10.1245/s10434-025-18693-9.